Edina Boros
Psychiatric/Mental Health · Las Vegas, NVNPI 1831602325
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.9% of the total across 247 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 19 manufacturers, the largest accounting for just 20.5% — the pattern of someone who eats at a lot of different presentations. Among psychiatric/mental health clinicians in NV with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 247 payments — averaging $36.68 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$2K
- Alkermes, Inc.$1K
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$989
- Otsuka America Pharmaceutical, Inc.$913
- Neurocrine Biosciences, Inc.$903
- Vanda Pharmaceuticals Inc.$823
- plus $2K from 13 others
What the payments were for
- Food & beverage$9,053100%
- Education$60%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 48 | $1,853 |
| Alkermes, Inc. | 34 | $1,183 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 27 | $989 |
| Otsuka America Pharmaceutical, Inc. | 25 | $913 |
| Neurocrine Biosciences, Inc. | 20 | $903 |
| Vanda Pharmaceuticals Inc. | 12 | $823 |
| Johnson & Johnson | 18 | $556 |
| E.r. Squibb & Sons, L.L.C. | 19 | $468 |
| Braeburn Inc. | 7 | $259 |
| Axsome Therapeutics, Inc. | 5 | $211 |
| Almatica Pharma LLC | 7 | $168 |
| Supernus Pharmaceuticals, Inc. | 5 | $155 |
| Takeda Pharmaceuticals U.S.A., Inc. | 6 | $133 |
| Teva Pharmaceuticals USA, Inc. | 1 | $124 |
| Shield Therapeutics Inc | 1 | $119 |
| Indivior Inc. | 5 | $102 |
| Sage Therapeutics, LLC | 3 | $44 |
| Lundbeck LLC | 2 | $36 |
| Corium, LLC | 2 | $19 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$9,059 in reported general payments places this provider in the 95th percentile of 362 psychiatric/mental health providers in Nevada.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Duloxetine Hcl | 21 | $385 |
| Trazodone Hcl | 19 | $318 |
| Quetiapine Fumarate | 11 | $100 |
Paid to pharmacies, not to this prescriber.
Other psychiatric/mental health in Las Vegas
- Michelle GiddingsLas Vegas$131K
- Patrick ApiladoLas Vegas$19K
- Joshua HamiltonLas Vegas$17K
- Sydney EganLas Vegas$14K
- Ma Victoria EscardaLas Vegas$12K
- Carminia SalvacionLas Vegas$12K
- Valentina AkohLas Vegas$12K
- Angela WilsonLas Vegas$11K
- Michael MathisenLas Vegas$10K
- Salem FitsumLas Vegas$9K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.